Bin YangKaiyuan WangDong ZhangBingjun SunBin JiLin WeiZhenbao LiMenglin WangXuanbo ZhangHaotian ZhangQiming KanCong LuoYongjun WangZhonggui HeJin Sun
In the context of prodrug nanomedicines for cancer therapy, one of the great challenges is the slow and variable release of the parent drug in tumors.
Jingmou YuMengqi LiuChao ZhangLizhen ChengChangchun PengDengzhao JiangWenbo LiuHong‐Guang JinJin Ren
Bingjun SunYao ChenYu HanChen WangXuanbo ZhangHanqing ZhaoQin ChenZhonggui HeCong LuoJin Sun
Wen Jiao HanMin WangHuaming HeYifan JiangChunhua LüXian-kun Tu
Mengyao ChenJingxian YangLulu ZhouXiaochun HuChunhui WangKeke ChaiRuihao LiLei FengYanting SunChunyan DongShuo Shi
Mo ZhangQingqing DouGe GaoXu FanSiao YangHongjin LvJing Wang